Sodium-glucose cotransporter 2 inhibitors and cardiovascular outcomes.

about

Sodium-glucose cotransporter 2 inhibitors and cardiovascular outcomes.

Item

http://www.wikidata.org/entity/Q38783203

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Sodium-glucose cotransporter 2 inhibitors and cardiovascular outcomes.

@en

type

Item

label

Sodium-glucose cotransporter 2 inhibitors and cardiovascular outcomes.

@en

prefLabel

Sodium-glucose cotransporter 2 inhibitors and cardiovascular outcomes.

@en

P1476

Sodium-glucose cotransporter 2 inhibitors and cardiovascular outcomes.

@en

P2093

Helmut O Steinberg

http://www.w3.org/2001/XMLSchema#string

P2860

Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Efficacy, safety and regulatory status of SGLT2 inhibitors: focus on canagliflozin

Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

Alogliptin after acute coronary syndrome in patients with type 2 diabetes

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

Effects of intensive glucose lowering in type 2 diabetes

P304

398-408

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/00325481.2016.1168687

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

128

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26999348

http://www.w3.org/2001/XMLSchema#string